Your shopping cart is currently empty

SNT-8370 is an orally active inhibitor of VAP-1 (IC50: 10 nM) and myeloperoxidase (MPO) (IC50: 17 nM), exhibiting 100-1000 times greater inhibitory potency on VAP-1 and MPO compared to other mammalian peroxidases. It effectively suppresses MPO-mediated LDL lipid peroxidation and reduces leukocyte infiltration in acute inflammatory lung injury models. SNT-8370 is an anti-inflammatory compound suitable for research on inflammatory diseases.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | SNT-8370 is an orally active inhibitor of VAP-1 (IC50: 10 nM) and myeloperoxidase (MPO) (IC50: 17 nM), exhibiting 100-1000 times greater inhibitory potency on VAP-1 and MPO compared to other mammalian peroxidases. It effectively suppresses MPO-mediated LDL lipid peroxidation and reduces leukocyte infiltration in acute inflammatory lung injury models. SNT-8370 is an anti-inflammatory compound suitable for research on inflammatory diseases. |
| Formula | C16H16FN5O2S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.